Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Machatha currently holds 221,799 shares of Aldeyra Therapeutics, Inc. (ALDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Machatha has been a net seller of ALDX stock. They have purchased $0 and sold $324.8K worth of shares.
Stephen Machatha's most recent insider trade was on Aug 11, 2025, when they sold 22,073 shares at $5.15 per share.
Stephen Machatha serves as Executive at Aldeyra Therapeutics, Inc. (ALDX). They have executed 8 insider transactions totaling $324.8K over their tenure at the company.
Stephen Machatha holds the position of Executive at Aldeyra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Stephen Machatha has shown a selling trading pattern, with $0 in total purchases and $324.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen Machatha was on Aug 11, 2025, when they sold $113.7K worth of ALDX shares. This transaction involved 22,073 shares at $5.15 per share.
Stephen Machatha currently owns 221,799 shares of Aldeyra Therapeutics, Inc. (ALDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Machatha's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Machatha has 8 Form 4 filings on record as an insider at Aldeyra Therapeutics, Inc..
Set alerts for Stephen Machatha and 40,000+ other insiders.